Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Danner

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Quality & Safety in Health Care|June 7, 2003
QUOTE-HIV: an instrument for assessing quality of HIV care from the patients' perspectiveC F Hekkink, H J Sixma, L Wigersma, et al.
AIDS (London, England)|June 21, 2001
T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapyS Kostense, F M Raaphorst, J Joling, et al.
JAMA|July 10, 1996
Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working GroupS Staszewski, C Loveday, J J Picazo, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responsesD W Notermans, J J de Jong, J Goudsmit, et al.
The Journal of Clinical Investigation|December 1, 1988
Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occursF Miedema, A J Petit, F G Terpstra, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF)P J Bakker, S A Danner, C H ten Napel, et al.
Journal of Virological Methods|August 1, 1987
Pathogenesis of HIV and its implications for serodiagnosis and monitoring of antiviral therapyJ Goudsmit, J M Lange, W J Krone, et al.
AIDS (London, England)|February 1, 1988
Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudineJ de Gans, J M Lange, M M Derix, et al.
AIDS (London, England)|April 20, 1999
Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogsJ J de Jong, J Goudsmit, V V Lukashov, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 7, 1998
Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agentsN G Pakker, M T Roos, R van Leeuwen, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Quality & Safety in Health Care|June 7, 2003
QUOTE-HIV: an instrument for assessing quality of HIV care from the patients' perspectiveC F Hekkink, H J Sixma, L Wigersma, et al.
AIDS (London, England)|June 21, 2001
T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapyS Kostense, F M Raaphorst, J Joling, et al.
JAMA|July 10, 1996
Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working GroupS Staszewski, C Loveday, J J Picazo, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responsesD W Notermans, J J de Jong, J Goudsmit, et al.
The Journal of Clinical Investigation|December 1, 1988
Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occursF Miedema, A J Petit, F G Terpstra, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF)P J Bakker, S A Danner, C H ten Napel, et al.
Journal of Virological Methods|August 1, 1987
Pathogenesis of HIV and its implications for serodiagnosis and monitoring of antiviral therapyJ Goudsmit, J M Lange, W J Krone, et al.
AIDS (London, England)|February 1, 1988
Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudineJ de Gans, J M Lange, M M Derix, et al.
AIDS (London, England)|April 20, 1999
Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogsJ J de Jong, J Goudsmit, V V Lukashov, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 7, 1998
Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agentsN G Pakker, M T Roos, R van Leeuwen, et al.
Pageof 15